These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31276685)

  • 21. Amorphous Formulation and in Vitro Performance Testing of Instantly Disintegrating Buccal Tablets for the Emergency Delivery of Naloxone.
    Alqurshi A; Kumar Z; McDonald R; Strang J; Buanz A; Ahmed S; Allen E; Cameron P; Rickard JA; Sandhu V; Holt C; Stansfield R; Taylor D; Forbes B; Royall PG
    Mol Pharm; 2016 May; 13(5):1688-98. PubMed ID: 26977787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
    Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK
    Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.
    Karimi K; Katona G; Csóka I; Ambrus R
    J Pharm Biomed Anal; 2018 Jan; 148():73-79. PubMed ID: 28965047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrative Salt Selection and Formulation Optimization: Perspectives of Disproportionation and Microenvironmental pH Modulation.
    Mohan S; Li Y; Chu K; De La Paz L; Sperger D; Shi B; Foti C; Rucker V; Lai C
    Mol Pharm; 2024 May; 21(5):2590-2605. PubMed ID: 38656981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of Spatial Heterogeneity of Salt Disproportionation in Tablets by Synchrotron X-ray Diffractometry.
    Koranne S; Govindarajan R; Suryanarayanan R
    Mol Pharm; 2017 Apr; 14(4):1133-1144. PubMed ID: 28195490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-destructive determination of the coating film thickness by X-ray powder diffractometry and correlation with the dissolution behavior of film-coated tablets.
    Yamada H; Terada K; Suryanarayanan R
    J Pharm Biomed Anal; 2010 Mar; 51(4):952-7. PubMed ID: 19945243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of excipient properties, water activity, and water content on the disproportionation of a pharmaceutical salt.
    Patel MA; Luthra S; Shamblin SL; Arora KK; Krzyzaniak JF; Taylor LS
    Int J Pharm; 2018 Jul; 546(1-2):226-234. PubMed ID: 29772284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemometric Models for Quantification of Carbamazepine Anhydrous and Dihydrate Forms in the Formulation.
    Barakh Ali SF; Rahman Z; Dharani S; Afrooz H; Khan MA
    J Pharm Sci; 2019 Mar; 108(3):1211-1219. PubMed ID: 30773201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multivariate Quantification of the Solid State Phase Composition of Co-Amorphous Naproxen-Indomethacin.
    Beyer A; Grohganz H; Löbmann K; Rades T; Leopold CS
    Molecules; 2015 Oct; 20(10):19571-87. PubMed ID: 26516832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of tablet characteristics from residual stress distribution estimated by the finite element method.
    Hayashi Y; Miura T; Shimada T; Onuki Y; Obata Y; Takayama K
    J Pharm Sci; 2013 Oct; 102(10):3678-86. PubMed ID: 23897300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Metallic Stearates on Disproportionation of Hydrochloride Salts of Weak Bases in Solid-State Formulations.
    Nie H; Xu W; Ren J; Taylor LS; Marsac PJ; John CT; Byrn SR
    Mol Pharm; 2016 Oct; 13(10):3541-3552. PubMed ID: 27542728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the analytical methods (solid state NMR, FT-IR, PXRD) in the analysis of the solid drug forms with low concentration of an active ingredient - 17-β-estradiol case.
    Szeleszczuk Ł; Jurczak E; Zielińska-Pisklak M; Harwacki J; Pisklak DM
    J Pharm Biomed Anal; 2018 Feb; 149():160-165. PubMed ID: 29121569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural characterization of iron oxide/hydroxide nanoparticles in nine different parenteral drugs for the treatment of iron deficiency anaemia by electron diffraction (ED) and X-ray powder diffraction (XRPD).
    Fütterer S; Andrusenko I; Kolb U; Hofmeister W; Langguth P
    J Pharm Biomed Anal; 2013 Dec; 86():151-60. PubMed ID: 23998966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Degradation Chemistry of Prasugrel Hydrochloride: Part 1-Drug Substance.
    Baertschi SW; Maxwell-Backer L; Clemens M; Smitka TA; Draper JR; Taylor KW; Kaerner A; Jansen PJ
    J Pharm Sci; 2019 Sep; 108(9):2842-2857. PubMed ID: 30981754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative analysis of the active tablet ingredient by powder X-ray diffractometry.
    Suryanarayanan R; Herman CS
    Pharm Res; 1991 Mar; 8(3):393-9. PubMed ID: 1905009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heat-Stable Dry Powder Oxytocin Formulations for Delivery by Oral Inhalation.
    Fabio K; Curley K; Guarneri J; Adamo B; Laurenzi B; Grant M; Offord R; Kraft K; Leone-Bay A
    AAPS PharmSciTech; 2015 Dec; 16(6):1299-306. PubMed ID: 25776985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of processing methods on physico-mechanical properties of Ibuprofen/HPC-SSL formulation.
    Chaturvedi K; Gajera BY; Xu T; Shah H; Dave RH
    Pharm Dev Technol; 2018 Dec; 23(10):1108-1116. PubMed ID: 29310491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmaceutical development of an amorphous solid dispersion formulation of elacridar hydrochloride for proof-of-concept clinical studies.
    Sawicki E; Schellens JH; Beijnen JH; Nuijen B
    Drug Dev Ind Pharm; 2017 Apr; 43(4):584-594. PubMed ID: 28010129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach.
    Karimi K; Pallagi E; Szabó-Révész P; Csóka I; Ambrus R
    Drug Des Devel Ther; 2016; 10():3331-3343. PubMed ID: 27784991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A compression behavior classification system of pharmaceutical powders for accelerating direct compression tablet formulation design.
    Dai S; Xu B; Zhang Z; Yu J; Wang F; Shi X; Qiao Y
    Int J Pharm; 2019 Dec; 572():118742. PubMed ID: 31648016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.